国产日韩欧美一区二区三区三州_亚洲少妇熟女av_久久久久亚洲av国产精品_波多野结衣网站一区二区_亚洲欧美色片在线91_国产亚洲精品精品国产优播av_日本一区二区三区波多野结衣 _久久国产av不卡

?

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

2021-01-07 23:21:09JohnStoneetal
四川生理科學(xué)雜志 2021年1期

John H Stone, et al.

Background: The efficacy of interleukin-6 receptor blockade in hospitalized patients with c oronavirus disease 2019(Covid-19) who are not receiving mechanical ventilation is unclear.

Methods: We performed a randomized, double-blind, placebo-controlled trial involving patients with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, hyperinflammatory states, and at least two of the following signs: fever (body temperature >38°C), pulmonary infiltrates, or the need for supplemental oxygen in order to maintain an oxygen saturation greater than 92%.Patients were randomly assigned in a 2:1 ratio to receive standard care plus a single dose of either tocilizumab (8 mg per kilogram of body weight) or placebo.The primary outcome was intubation or death, assessed in a time-to-event analysis.The secondary efficacy outcomes were clinical worsening and discontinuation of supplemental oxygen among patients who had been receiving it at baseline, both assessed in time-to-event analyses.

Results: We enrolled 243 patients; 141 (58%) were men, and 102 (42%) were women.The median age was 59.8 years(range, 21.7 to 85.4), and 45% of the patients were Hispanic or Latino.The hazard ratio for intubation or death in the tocilizumab group as compared with the placebo group was 0.83 (95% confidence interval [CI], 0.38 to 1.81; P = 0.64), and the hazard ratio for disease worsening was 1.11 (95% CI, 0.59 to 2.10; P = 0.73).At 14 days, 18.0% of the patients in the tocilizumab group and 14.9% of the patients in the placebo group had had worsening of disease.The median time to discontinuation of supplemental oxygen was 5.0 days (95% CI, 3.8 to 7.6) in the tocilizumab group and 4.9 days (95% CI, 3.8 to 7.8) in the placebo group (P = 0.69).At 14 days, 24.6% of the patients in the tocilizumab group and 21.2% of the patients in the placebo group were still receiving supplemental oxygen.Patients who received tocilizumab had fewer serious infections than patients who received placebo.

Conclusions: Tocilizumab was not effective for preventing intubation or death in moderately ill hospitalized patients with Covid-19.Some benefit or harm cannot be ruled out, however, because the confidence intervals for efficacy comparisons were wide.(Funded by Genentech; ClinicalTrials.gov number, NCT04356937.).

治县。| 沁源县| 咸丰县| 郯城县| 九龙城区| 双柏县| 象山县| 鹤山市| 吐鲁番市| 霍邱县| 南阳市| 吴堡县| 皮山县| 大洼县| 霍林郭勒市| 丹寨县| 察雅县| 正安县| 阳新县| 嘉兴市| 四平市| 太白县| 增城市| 通州市| 云林县| 广元市| 诸城市| 遂昌县| 体育| 康定县| 鸡西市| 边坝县| 新闻| 武陟县| 察隅县| 平塘县| 龙陵县| 晴隆县| 巴南区| 镇坪县| 兴山县|